FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

ALSO NOTED: Bavarian Nordic earns milestone payment; Cyclacel acquires Align Pharmaceuticals; and much more...

Tools

> Bavarian Nordic has earned a $50 million advanced payment for achieving milestones outlined in its contract to provide smallpox vaccine to the U.S. government. Report

> Coley Pharmaceuticals of Wellesley, MA has adopted a shareholder rights program. Release

> Cyclacel Pharmaceuticals has acquired Align Pharmaceuticals for about $3.5 million in cash. Release

> UK-based Shire Pharmaceuticals is selling a block of medicines to Almirall of Spain for $213 million. Report

> A Florida jury ruled for Merck in yet another Vioxx case, bringing the drug maker's record to 11-5 in trials related to the drug. Report

> Eli Lilly is owning up to Zyprexa's ills in new warnings added to the medicine's label. Report

And Finally...Too much debt? Blame it on your genes. New research indicates that our genes may play a key role in our economic behavior. Report

Bookmark and Share
Get Your FREE FierceBiotech Email Newsletter:
Be the first to comment
More stories about Shire Pharmaceuticals   Zyprexa   genes   Eli Lilly   Merck   Vioxx  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.